Neurosight raises €285K Seed round
27 October 2022· London, United Kingdom· health, talent_assessment, ai, biotech, b2b, pure_software
The capital infusion was intended for strategic expansion, product development, market penetration, and operational scaling of its neuroscience-powered talent assessment platform.
Investors
LeadSFC Capital
Also participating
Creative Destruction LabKin CapitalMassLight
About Neurosight
Stage
Seed
Headquarters
London, United Kingdom
Founded
2019
Team Size
6–20
Sectors
healthtalent_assessmentaibiotechb2bpure_software